+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In Vitro Protein Expression Systems - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • July 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139811
The global market for In Vitro Protein Expression Systems is estimated at US$203 Million in 2023 and is projected to reach US$276.9 Million by 2030, growing at a CAGR of 4.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the E-Coli In Vitro Protein Expression Systems segment, which is expected to reach US$147.7 Million by 2030 with a CAGR of a 5%. The Mammalian In Vitro Protein Expression Systems segment is also set to grow at 4.2% CAGR over the next 7 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $60 Million in 2023, and China, forecasted to grow at an impressive 4.2% CAGR to reach $48.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global In Vitro Protein Expression Systems Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global In Vitro Protein Expression Systems Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global In Vitro Protein Expression Systems Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Bioneer Corporation, biotechrabbit GmbH, CellFree Sciences Co., Ltd., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 12 Featured):

  • Bioneer Corporation
  • biotechrabbit GmbH
  • CellFree Sciences Co., Ltd.
  • Cube Biotech GmbH
  • GeneCopoeia, Inc.
  • Jena Bioscience GmbH
  • New England Biolabs, Inc.
  • Promega Corporation
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • In Vitro Protein Expression Systems - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 4: World In Vitro Protein Expression Systems Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • Table 5: World Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for In Vitro Protein Expression Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for In Vitro Protein Expression Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for E-Coli by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for E-Coli by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for E-Coli by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Mammalian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Mammalian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Mammalian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 28: USA 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 29: USA Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 30: USA Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 31: USA 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 34: Canada 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 35: Canada Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 36: Canada Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 37: Canada 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
JAPAN
  • In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 40: Japan 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 41: Japan Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 42: Japan Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 43: Japan 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
CHINA
  • In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 44: China Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 45: China Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 46: China 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 47: China Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 48: China Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 49: China 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
EUROPE
  • In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for In Vitro Protein Expression Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for In Vitro Protein Expression Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 57: Europe Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 58: Europe 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
FRANCE
  • In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 59: France Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 60: France Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 61: France 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 62: France Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 63: France Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 64: France 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
GERMANY
  • In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 65: Germany Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 66: Germany Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 67: Germany 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 68: Germany Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 69: Germany Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 70: Germany 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
ITALY
  • Table 71: Italy Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 72: Italy Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 73: Italy 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 74: Italy Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 75: Italy Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 76: Italy 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 77: UK Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 78: UK Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 79: UK 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 80: UK Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 81: UK Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 82: UK 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 83: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 84: Rest of Europe Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 85: Rest of Europe 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 87: Rest of Europe Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 88: Rest of Europe 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • In Vitro Protein Expression Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 89: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 90: Asia-Pacific Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 91: Asia-Pacific 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 93: Asia-Pacific Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 94: Asia-Pacific 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
REST OF WORLD
  • Table 95: Rest of World Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 96: Rest of World Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 97: Rest of World 16-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations and Academic & Research Institutes for the Years 2014, 2024 & 2030
  • Table 98: Rest of World Recent Past, Current & Future Analysis for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 99: Rest of World Historic Review for In Vitro Protein Expression Systems by Product - E-Coli, Mammalian and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 100: Rest of World 16-Year Perspective for In Vitro Protein Expression Systems by Product - Percentage Breakdown of Value Sales for E-Coli, Mammalian and Other Product Types for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bioneer Corporation
  • biotechrabbit GmbH
  • CellFree Sciences Co., Ltd.
  • Cube Biotech GmbH
  • GeneCopoeia, Inc.
  • Jena Bioscience GmbH
  • New England Biolabs, Inc.
  • Promega Corporation
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

Table Information